Coya Therapeutics Inc (COYA)
8.79
+0.29
(+3.41%)
USD |
NASDAQ |
May 17, 16:00
8.79
0.00 (0.00%)
After-Hours: 20:00
Coya Therapeutics Price to Book Value: 3.940 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.940 |
| May 16, 2024 | 3.836 |
| May 15, 2024 | 3.791 |
| May 14, 2024 | 3.723 |
| May 13, 2024 | 3.646 |
| May 10, 2024 | 3.705 |
| May 09, 2024 | 3.818 |
| May 08, 2024 | 3.624 |
| May 07, 2024 | 3.655 |
| May 06, 2024 | 3.762 |
| May 03, 2024 | 3.916 |
| May 02, 2024 | 3.961 |
| May 01, 2024 | 3.911 |
| April 30, 2024 | 4.083 |
| April 29, 2024 | 3.780 |
| April 26, 2024 | 3.880 |
| April 25, 2024 | 3.803 |
| April 24, 2024 | 3.794 |
| April 23, 2024 | 3.618 |
| April 22, 2024 | 3.604 |
| April 19, 2024 | 3.609 |
| April 18, 2024 | 3.808 |
| April 17, 2024 | 3.717 |
| April 16, 2024 | 3.686 |
| April 15, 2024 | 3.776 |
| Date | Value |
|---|---|
| April 12, 2024 | 4.069 |
| April 11, 2024 | 4.123 |
| April 10, 2024 | 4.168 |
| April 09, 2024 | 4.218 |
| April 08, 2024 | 4.349 |
| April 05, 2024 | 4.313 |
| April 04, 2024 | 4.132 |
| April 03, 2024 | 4.471 |
| April 02, 2024 | 4.484 |
| April 01, 2024 | 4.421 |
| March 31, 2024 | |
| March 28, 2024 | 4.065 |
| March 27, 2024 | 3.954 |
| March 26, 2024 | 3.626 |
| March 25, 2024 | 3.630 |
| March 22, 2024 | 3.983 |
| March 21, 2024 | 4.044 |
| March 20, 2024 | 4.065 |
| March 19, 2024 | 4.110 |
| March 18, 2024 | 4.024 |
| March 15, 2024 | 4.134 |
| March 14, 2024 | 4.081 |
| March 13, 2024 | 3.995 |
| March 12, 2024 | 3.677 |
| March 11, 2024 | 3.983 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.260
Minimum
Jan 16 2024
10.83
Maximum
Dec 28 2023
3.811
Average
3.215
Median
Jun 13 2023
Price to Book Value Benchmarks
| Virpax Pharmaceuticals Inc | -- |
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 2.107 |
| IGC Pharma Inc | 3.942 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 8.79 |
| Earnings Yield | -9.74% |
| Market Cap | 127.62M |